Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

723
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
723
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Differential perovskite hemispherical photodetector for intelligent imaging and location tracking.

Nature communications·2024
Same author

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.

BMC infectious diseases·2024
Same author

Morphological Profiling for Drug Discovery in the Era of Deep Learning.

ArXiv·2024
Same author

The epigenetic regulatory effect of histone acetylation and deacetylation on skeletal muscle metabolism-a review.

Frontiers in physiology·2023
Same author

A case of brain arteriovenous malformation treated by high-pressure cooker technique assisted with anhydrous alcohol embolization: A case report.

Medicine·2023
Same author

Neutrophil heterogeneity and aging: implications for COVID-19 and wound healing.

Frontiers in immunology·2023

相关实验视频

Updated: May 12, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.1K

使用心脏性休克分类系统来预测心脏切除术后的休克死亡率.

Yiwen Wang1, Chenglong Li1, Liangshan Wang1

  • 1Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

JACC. Asia
|May 8, 2025
PubMed
概括

在心脏手术患者中,心脏性休克 (CS) 是常见的,影响11.1%. 心血管血管图谱与干预学会 (SCAI) 的分类有效预测住院死亡风险,显示在CS严重程度增加时死亡率更高.

关键词:
心脏外科手术的心脏手术心脏发生的冲击是心脏发生的冲击.冠状动脉绕道移植冠状动脉绕道移植死亡率 死亡率结果结果结果结果.在心脏切除术后,进行心脏切除术.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
08:14

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research

Published on: March 22, 2024

1.2K

相关实验视频

Last Updated: May 12, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
08:14

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research

Published on: March 22, 2024

1.2K

科学领域:

  • 心脏病学 心脏病学
  • 关键护理医学 关键护理医学
  • 心脏外科手术 心脏外科手术

背景情况:

  • 心脏性休克 (CS) 是一种影响血液动力学稳定的危急状况.
  • 脑神经系统管理因休克严重程度和患者群体而异.
  • 心血管血管图谱和干预学会 (SCAI) 推出了一种新的CS分类系统.

研究的目的:

  • 评估在心脏切开术后患者中定义CS阶段的参数.
  • 评估SCAI CS分类的诊断实用性,用于预测心脏手术患者的结果.

主要方法:

  • 一项对8,335名成人心脏手术患者 (2022年1月至12月) 的回顾性观察研究.
  • 根据乳酸水平和干预措施 (血管压缩剂,机械循环支持) 患者被分为5组.
  • 主要结局是住院死亡率.

主要成果:

  • 脑脊髓病发病率为11.1% (970名患者).
  • 在SCAI阶段A-E的分布显示出显著差异 (P < 0.001).
  • 随着CS严重程度的增加,住院死亡率逐渐增加,从A阶段的0.4%到E阶段的31.0% (P < 0.001). 在AUC是0.781.1.

结论:

  • 在心脏切开术后的患者中,CS影响11.1%.
  • 对CS严重性的SCAI衍生标准与该人群的住院死亡率有很好的相关性.